Your browser doesn't support javascript.
loading
Current status and future prospects of chimeric antigen receptor-T cell therapy in lymphoma research: A bibliometric analysis.
Ou, Lijia; Su, Chang; Liang, Liang; Duan, Qintong; Li, Yufeng; Zang, Hui; He, Yizi; Zeng, Ruolan; Li, Yajun; Zhou, Hui; Xiao, Ling.
Afiliación
  • Ou L; Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan, China.
  • Su C; Department of Histology and Embryology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
  • Liang L; Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan, China.
  • Duan Q; Department of Histology and Embryology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
  • Li Y; Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan, China.
  • Zang H; Graduate Collaborative Training Base of Hunan Cancer Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
  • He Y; Department of Histology and Embryology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
  • Zeng R; Department of Histology and Embryology, Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
  • Li Y; Department of Human Anatomy and Histoembryology of School of Basic Medical Sciences, Yiyang Medical College, Yiyang, Hunan, China.
  • Zhou H; Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan, China.
  • Xiao L; Department of Lymphoma & Hematology, The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan, China.
Hum Vaccin Immunother ; 19(3): 2267865, 2023 12 15.
Article en En | MEDLINE | ID: mdl-37846106

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Linfoma Límite: Humans Idioma: En Revista: Hum Vaccin Immunother Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Linfoma Límite: Humans Idioma: En Revista: Hum Vaccin Immunother Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos